MTEMMolecular Templates, Inc.

About Molecular Templates, Inc. (MTEM)

Molecular Templates, Inc. (MTEM) is a Biotechnology company headquartered in Austin, TX, United States whose shares trade over-the-counter on the Expert Market tier.

Molecular Templates is developing novel therapies in oncology and other serious diseases through its proprietary biologic engineered toxin body (ETB) drug platform. ETBs are targeted, can induce their own internalization, and can destroy cells through novel mechanisms of action.

MTEM key facts

Ticker symbol

MTEM

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Austin, TX, United States

Country of incorporation

US

Estimated market cap

$658.388 (as of Apr 10, 2025)

Shares outstanding

6,583,880

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Latest filing

8K Report (Dec 30, 2024)

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with M